Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying regulatory oversight through new enforcement actions, capacity building, and mandatory training initiatives, while also signaling support for export-oriented agriculture via NEPC registration guidance. For Nigerian SMBs, this means stricter compliance requirements for pharmaceutical and healthcare product distribution, potential supply chain disruptions from blacklisted and watchlisted products, and new opportunities in regulated export markets.
Pharmaceuticals and healthcare
Food and drug importation
Agriculture and export
Retail and distribution
Clinical research
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated 600 pharmacists into a voluntary reserve group to enhance regulatory capacity and pharmacovigilance across Nigeria.
SMBs in pharmaceutical retail and distribution may face increased inspections and compliance checks, but also benefit from improved regulatory support and faster resolution of issues.
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
NAFDAC and NHREC rescheduled mandatory training on clinical trial regulations for stakeholders, emphasizing compliance with updated guidelines.
SMBs involved in clinical trials or contract research must ensure staff attend the training to avoid penalties and maintain eligibility for trial-related contracts.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC blacklisted Ayrtons Saunders Ltd, UK, prohibiting the importation, distribution, and sale of its products in Nigeria.
SMBs importing or distributing products from this company must immediately cease and dispose of affected stock, and may face supply chain disruptions; they should verify all foreign suppliers against NAFDAC's blacklist.
Public Alert No. 043/2026-NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist Pending Regulatory Investigation
NAFDAC
NAFDAC placed products marketed by Mofus Nigeria Ltd on a watchlist pending investigation into regulatory compliance.
SMBs selling or distributing these products should suspend sales immediately, cooperate with investigations, and prepare for potential recalls or legal action.
Public Alert No. 042/2026-Alert on the Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
NAFDAC
NAFDAC seized suspected substandard and falsified antimalarial medicine BPPL Artemether/Lumefantrine 80mg/480mg and warned against its use.
SMB pharmacies and PPMVs must remove this product from shelves, source antimalarials only from approved suppliers, and educate customers on the risks of counterfeit drugs.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
A guide on registering fish farms with the Nigerian Export Promotion Council (NEPC) to facilitate fish and fishery product exports.
SMBs in aquaculture can leverage this guide to access export markets, but must comply with NEPC registration and quality standards to avoid rejection at borders.
Increased NAFDAC enforcement may lead to supply chain disruptions for SMBs dealing in blacklisted or watchlisted products.
Mandatory training for clinical trials indicates tighter regulation and potential barriers for SMBs in research.
Export opportunities in agriculture are expanding, but require formal registration and compliance.
Pharmacist reserve group may improve regulatory responsiveness, benefiting compliant SMBs.
Counterfeit drug alerts highlight the need for robust supplier verification and quality control.
1
Immediately check inventory for products from Ayrtons Saunders Ltd, Mofus Nigeria Ltd, and the seized BPPL Artemether/Lumefantrine; remove and quarantine if found.
2
Verify all foreign suppliers against NAFDAC's blacklist and watchlist before importing.
3
Register for the NAFDAC/NHREC mandatory clinical trial training if involved in clinical research.
4
For fish farmers, initiate NEPC registration to access export markets and adhere to quality standards.
5
Enhance internal quality control and pharmacovigilance procedures to detect substandard products.
6
Stay updated with NAFDAC public alerts and notices through their website and official channels.